Obid, Laihana .
HRN: 24-46-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/29/2024
02/05/2024
IV
500mg
Q8
Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes